Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
24 Dec 2021 10:35 CET |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
24 Dec 2021 10:35 CET |
EXACT THERAPEUTICS | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
22 Dec 2021 14:22 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) | 20103010 Biotechnology | Non-regulatory press releases |
21 Dec 2021 08:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS Awarded NOK 7.4 M Grant for the Development of its Next Generation Ultrasound Transducer and Navigation System for ACT® | 20103010 Biotechnology | Non-regulatory press releases |
13 Dec 2021 08:06 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2021 | 20103010 Biotechnology | Non-regulatory press releases |
13 Dec 2021 08:00 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2021 | 20103010 Biotechnology | Non-regulatory press releases |
06 Dec 2021 07:00 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
05 Dec 2021 15:33 CET |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS - MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
03 Dec 2021 17:54 CET |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS – PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING – VALG AV NYTT STYREMEDLEM | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
03 Dec 2021 17:53 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS Minutes From Extraordinary General Meeting – Appointment Of New Board Member | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Nov 2021 21:27 CET |
EXACT THERAPEUTICS | To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Nov 2021 21:25 CET |
EXACT THERAPEUTICS | Til aksjonærene i EXACT Therapeutics AS - INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
25 Nov 2021 18:00 CET |
EXACT THERAPEUTICS | To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Nov 2021 18:00 CET |
EXACT THERAPEUTICS | Til aksjonærene i EXACT Therapeutics AS - INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
18 Nov 2021 09:57 CET |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX) - PROVIDES STRATEGIC BUSINESS UPDATE | 20103010 Biotechnology | Non-regulatory press releases |
18 Nov 2021 07:00 CET |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX) - PROVIDES STRATEGIC BUSINESS UPDATE | 20103010 Biotechnology | Non-regulatory press releases |
19 Oct 2021 23:58 CEST |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS ANNOUNCES CHANGES TO THE MANAGEMENT TEAM | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
22 Sep 2021 17:55 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS announces interim results for first half 2021 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
26 Aug 2021 16:52 CEST |
EXACT THERAPEUTICS | EXACT THERAPEUTICS TO PRESENT AT PARETO SECURITIES 12th ANNUAL HEALTHCARE CONFERENCE | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
30 Jun 2021 15:20 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
30 Jun 2021 11:17 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
25 Jun 2021 12:31 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
07 Jun 2021 10:02 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notices | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
07 Jun 2021 09:55 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Share Capital Increase | 20103010 Biotechnology | Total number of voting rights and capital |
02 Jun 2021 00:18 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Minutes of Annual General Meeting 2021 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
28 May 2021 13:37 CEST |
EXACT THERAPEUTICS | EXACT THERAPEUTICS ANNOUNCES CLINICAL TRIAL UPDATE | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 May 2021 11:51 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Annual General Meeting 2021 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
19 May 2021 16:55 CEST |
EXACT THERAPEUTICS | EXACT THERAPEUTICS ANNOUNCES GRANTING OF PATENT IN JAPAN FOR ACOUSTIC CLUSTER THERAPY | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
18 May 2021 22:20 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS: ANNUAL REPORT 2020 | 20103010 Biotechnology | Annual financial and audit Reports |